GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stereotaxis Inc (AMEX:STXS) » Definitions » Cyclically Adjusted PS Ratio

STXS (Stereotaxis) Cyclically Adjusted PS Ratio : 2.37 (As of May. 27, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Stereotaxis Cyclically Adjusted PS Ratio?

As of today (2025-05-27), Stereotaxis's current share price is $2.13. Stereotaxis's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $0.90. Stereotaxis's Cyclically Adjusted PS Ratio for today is 2.37.

The historical rank and industry rank for Stereotaxis's Cyclically Adjusted PS Ratio or its related term are showing as below:

STXS' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.07   Med: 1.03   Max: 3.68
Current: 2.3

During the past years, Stereotaxis's highest Cyclically Adjusted PS Ratio was 3.68. The lowest was 0.07. And the median was 1.03.

STXS's Cyclically Adjusted PS Ratio is ranked worse than
51.67% of 480 companies
in the Medical Devices & Instruments industry
Industry Median: 2.215 vs STXS: 2.30

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Stereotaxis's adjusted revenue per share data for the three months ended in Mar. 2025 was $0.085. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.90 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Stereotaxis Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Stereotaxis's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stereotaxis Cyclically Adjusted PS Ratio Chart

Stereotaxis Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.78 2.89 1.39 1.57 2.42

Stereotaxis Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.41 1.75 2.04 2.42 1.95

Competitive Comparison of Stereotaxis's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Stereotaxis's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stereotaxis's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stereotaxis's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Stereotaxis's Cyclically Adjusted PS Ratio falls into.


;
;

Stereotaxis Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Stereotaxis's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=2.13/0.90
=2.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stereotaxis's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Stereotaxis's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.085/134.9266*134.9266
=0.085

Current CPI (Mar. 2025) = 134.9266.

Stereotaxis Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.460 100.684 0.616
201509 0.439 100.392 0.590
201512 0.427 99.792 0.577
201603 0.400 100.470 0.537
201606 0.361 101.688 0.479
201609 0.381 101.861 0.505
201612 0.333 101.863 0.441
201703 0.312 102.862 0.409
201706 0.375 103.349 0.490
201709 0.358 104.136 0.464
201712 0.331 104.011 0.429
201803 0.210 105.290 0.269
201806 0.128 106.317 0.162
201809 0.128 106.507 0.162
201812 0.123 105.998 0.157
201903 0.118 107.251 0.148
201906 0.113 108.070 0.141
201909 0.128 108.329 0.159
201912 0.101 108.420 0.126
202003 0.082 108.902 0.102
202006 0.075 108.767 0.093
202009 0.117 109.815 0.144
202012 0.091 109.897 0.112
202103 0.115 111.754 0.139
202106 0.120 114.631 0.141
202109 0.120 115.734 0.140
202112 0.109 117.630 0.125
202203 0.093 121.301 0.103
202206 0.081 125.017 0.087
202209 0.101 125.227 0.109
202212 0.096 125.222 0.103
202303 0.086 127.348 0.091
202306 0.097 128.729 0.102
202309 0.095 129.860 0.099
202312 0.055 129.419 0.057
202403 0.082 131.776 0.084
202406 0.053 132.554 0.054
202409 0.107 133.029 0.109
202412 0.073 133.157 0.074
202503 0.085 134.927 0.085

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Stereotaxis  (AMEX:STXS) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Stereotaxis Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Stereotaxis's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Stereotaxis Business Description

Traded in Other Exchanges
Address
710 North Tucker Boulevard, Suite 110, St. Louis, MO, USA, 63101
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
Executives
Paul J Isaac 10 percent owner 530 FIFTH AVENUE, 20TH FLOOR, NEW YORK NY 10036
Myriam Curet director 1020 KIFER ROAD, SUNNYVALE CA 94086
David Benfer director 5 SELDEN AVENUE, BRANFORD CT 06404
Kimberly R. Peery officer: Chief Financial Officer C/O STEREOTAXIS, INC., 4320 FOREST PARK AVENUE: SUITE 100, ST. LOUIS MO 63108
Kevin M. Barry officer: Chief Legal Officer & Secretar 4320 FOREST PARK AVENUE, 100, ST. LOUIS MO 63108
Ross B Levin director 530 FIFTH AVENUE, 20TH FLOOR, NEW YORK NY 10036
Fariba Fischel Ghodsian 10 percent owner 10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
Dafna Capital Management Llc 10 percent owner 10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
David Leo Fischel director 10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
Arun Swarup Menawat director 2412 EIGHTH LINE, OAKVILLE A6 L6H6S9
Joe E Kiani director 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Paul Brathwaite officer: VP Research & Development C/O STEREOTAXIS, INC., 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Martin C Stammer officer: Chief Financial Officer C/O STEREOTAXIS, INC., 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Nathan Fischel director 10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
Duane Desisto director C/O INSULET CORPORATION, 9 OAK PARK DRIVE, BEDFORD MA 01730

Stereotaxis Headlines

From GuruFocus

Q2 2021 Stereotaxis Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q3 2020 Stereotaxis Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q4 2021 Stereotaxis Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q1 2024 Stereotaxis Inc Earnings Call Transcript

By GuruFocus Research 05-14-2024

Q2 2022 Stereotaxis Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q2 2023 Stereotaxis Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q1 2022 Stereotaxis Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q3 2024 Stereotaxis Inc Earnings Call Transcript

By GuruFocus News 11-12-2024

Q4 2022 Stereotaxis Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024